Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

O-GalNAc Modified Glycoprotein Assay Kit (FACS/Microscopy, Green Fluorescence) (ab235629)

O-GalNAc Modified Glycoprotein Assay Kit (FACS/Microscopy, Green Fluorescence) (ab235629)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Platform: Flow cytometer, Fluorescence microscope
  • Sample type: Adherent cells, Suspension cells

You may also be interested in

Product image
Anti-CACNA1C antibody [EPR22625-61] (ab234438)
Phenol red sodium salt, pH indicator (ab146337)
Product image
Recombinant Human Eph receptor A2 protein (His tag) (ab222423)
Product image
Human CEACAM1 knockout A549 cell lysate (ab257388)

Overview

  • Product name

    O-GalNAc Modified Glycoprotein Assay Kit (FACS/Microscopy, Green Fluorescence)
  • Sample type

    Adherent cells, Suspension cells
  • Product overview

    The O-GalNAc Modified Glycoprotein Assay Kit (FAC/Microscopy, Green Fluorescence)(ab235629) is a highly specific, simple and robust method for labeling and detection of O-GalNAc-glycosylated proteins within cells. The kit uses a modified galactosamine precursor that is fed directly into the cells, processed by the GalNAc salvage pathway to form the intermediate uridine diphospho (UDP)-GalNAz, which is recognized by GalNAc transferases in the Golgi and incorporated into the protein. Followed by click reaction with alkyne-containing dye, this system offers a powerful method for imaging the localization, trafficking, and dynamics of glycans, or detection by FACS for quantitative studies.

  • Notes

    Glycans are vital components of glycoproteins, glycolipids, and proteoglycans in all domains of life. Glycoproteins are grouped by the type of carbohydrate and amino acid linkage site. N-linked glycosylation is a modification of asparagine, whereas O-linked glycosylation occurs through the hydroxyl group of serine and threonine residues. Glycosylation occurs co- or post-translationally on >50% of eukaryotic proteins resulting in membrane-associated, intracellular, or secreted glycoproteins that are crucial in cellular processes, protein bioactivity and metabolic turnover. Attachment of O-linked mucin-type glycans is a common post-translational modification initiated by the addition of N-acetyl-galactosamine (GalNAc) to a Ser or Thr residue of newly assembled protein. Resulting GalNAc-(Ser/Thr) structure (Tn-antigen) can be further modified by the addition of either a sialic acid residue (sialyl-Tn), GlcNAc to form GlcNAc-GalNAc (core 3), or a galactose residue to form the GalGalNAc (core 1) structures respectively. The core 3 and 1 structures are then further extended to form long and branched complex O-glycans. The core 1 (TF or T antigen) acts like oncofetal antigen, overexpressed in cancerous and precancerous conditions due to the Golgi apparatus disorder. GalNAc linked to the first mannose of glycosylphosphatidylinositol (GPI) core has been previously reported to be heterogeneously present on mammalian GPI-anchored proteins.

  • Platform

    Flow cytometer, Fluorescence microscope

Properties

  • Storage instructions

    Store at -20°C. Please refer to protocols.
  • Components 100 tests
    Copper Reagent (100X) 1 x 100µl
    Fixative Solution 1 x 10ml
    Fluorescent Alkyne (100X) 1 x 100µl
    GalAz Label (1000X) 1 x 10µl
    Permeabilization Buffer (10X) 1 x 25ml
    Reducing Agent (20X) 1 x 500µl
    Total DNA Stain (1000X) 1 x 20µl
    Wash Buffer (10X) 1 x 25ml

Images

  • Jurkat cells cultured in presence of 1X GalAz Label for 24 hours at 37°C
    Jurkat cells cultured in presence of 1X GalAz Label for 24 hours at 37°C

    Jurkat cells (1 X 106 cells/ml) were cultured in presence of 1X GalAz Label for 24 hours at 37°C. Modified glycoproteins were detected according to the kit protocol and green fluorescence was analyzed by FACS (FL-1 channel). Negative control (white line), Background control (purple line), fluorescence corresponding to intracellular O-GalNAc-glycosylated proteins (green line).

  • Fluorescence microscopy analysis
    Fluorescence microscopy analysis

    Fluorescence Microscope images of cell surface (left panel) and subcellular localization (right panel) of O-GalNAc-glycosylated proteins in fixed HeLa cells.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to O-GalNAc Modified Glycoprotein Assay Kit (FACS/Microscopy, Green Fluorescence) (ab235629)

  •  
  • Product image

    O-GlcNAc Modified Glycoprotein Assay Kit (FACS/Microscopy, Green Fluorescence) (ab235633)

    Applications:

Clear all

Recently viewed products

  •  
  • Product image

    Anti-ALIX antibody [EPR15314] - N-terminal (ab186429)

  •  
  • Product image

    Anti-Thrombomodulin antibody [THBD/1591] - BSA and Azide free (ab269746)

  •  
  • Product image

    Anti-VPAC1 antibody [SP234] - BSA and Azide free (ab245743)

  •  
  • Product image

    Anti-CD22 antibody [OX97] - BSA and Azide free (ab244594)

  •  
  • Product image

    HRP Anti-MRP8 antibody [EPR3554] (ab201473)

  •  
  • Product image

    Rabbit monoclonal [RM118] Anti-Human IgG2 heavy chain (Biotin) (ab272184)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.